Get started
Author

Anahit Aznauryan

Observed names: A. Z. Aznauryan, A.Z Aznauryan, Anahit Z. Aznauryan
Observed institution: Yerevan State Medical University
ORCID: 0000-0002-9642-7740
Observed ORCID: 0000-0002-9642-7740
OpenAlex ID: A5111082387
Possibilities of dapagliflozin-induced cardioprotection on doxorubicin + cyclophosphamide mode of chemotherapy-induced cardiomyopathy
2023 · Ashot Avagimyan, Mohammad Sheibani, et al. · International Journal of Cardiology · 30
Translational aspects of doxorubicin-induced cardiotoxicity: What we have omitted for the past decades?
2025 · Ashot Avagimyan, Rosalinda Madonna, et al. · Vascular Pharmacology · 14
Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 1)
2024 · A. A. Avagimyan, M. Sheibani, et al. · Innovative medicine of Kuban · 10
PDF
Methotrexate & rheumatoid arthritis associated atherosclerosis: A narrative review of multidisciplinary approach for risk modification by the international board of experts
2023 · Ashot Avagimyan, Federica Fogacci, et al. · Current Problems in Cardiology · 8
Mitochondrial dysfunction associated with AC mode of chemotherapy intake
2020 · A.A Avagimyan, A.G Mrochek, et al. · European Heart Journal · 7
Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)
2025 · Ashot A. Avagimyan, Mohammad Sheibani, et al. · Innovative medicine of Kuban · 3
Cardiac Sarcoidosis: A Contemporary Concept of Forgotten Granulomatosis.
2023 · Ashot Avagimyan, Lusine Mkrtchyan, et al. · PubMed Central · 1
PDF
Works count: 7
Citation count: 73
H-index: 5
I10-index: 3
Year
Topic
Type